Notably, reducing CMTM8 expression can lead to the inhibition of pancreatic cancer metastasis, thus establishing CMTM8 as a potential therapeutic target for pancreatic cancer (Gardner et al., 2013; Shi et al., 2021). The gene discussed is CMTM8; the disease is familial pancreatic carcinoma.